Cargando…
ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread around the world. As of the end of June 2021, there were approximately 181 million confirmed cases and more than 3.9 million deaths across the globe. The colossal impact of coronavirus disease 2019 (COVID-19) is driving...
Autores principales: | Shakoor, Muhammad Tariq, Birkenbach, Mark P., Lynch, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the National Kidney Foundation, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285210/ https://www.ncbi.nlm.nih.gov/pubmed/34280507 http://dx.doi.org/10.1053/j.ajkd.2021.06.016 |
Ejemplares similares
-
Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine
por: Gilio, Michele, et al.
Publicado: (2022) -
MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination
por: Obata, Shota, et al.
Publicado: (2021) -
“Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine”: comment
por: Sookaromdee, Pathum, et al.
Publicado: (2022) -
Tachycardia following Pfizer-BioNTech COVID-19 vaccine
por: Martins-Filho, Paulo Ricardo
Publicado: (2023) -
Tachycardia following Pfizer-BioNTech COVID-19 vaccine
por: Martins-Filho, Paulo Ricardo
Publicado: (2023)